TNFSF10 and rheumatoid arthritis: To prepare RA joint targeting TU-NPs, the synthesized PLGA cores were loaded with hydroxychloroquine (HCQ), a first-line antirheumatic drug with low adverse effects, and further coated by the plasma membrane of UVECs, stably expressing TRAIL.